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Aims: To examine the vasodilatation induce by the NO donors, [Ru(terpy)(bdq)NO]3+ (TERPY) and sodium
nitroprusside (SNP), and to compare their effects in aortic rings from hypertensive 2K-1C and normotensive 2K
rats.
Main methods: Vascular reactivity was performed in aortic rings pre-contracted with phenylephrine
(Phe 100 nM). We have analyzed the maximal relaxation (Emax) and potency (pD2) of NO donors.
Key ﬁndings: Potency of SNP was greater than TERPY in both arterial groups. The vasodilatation induced by
TERPYwas greater in 2K than in 2K-1C, and itwas inhibited by sGC inhibitor ODQ in 2K and in 2K-1C aortic rings.
+ODQ did not alter the efﬁcacy to SNP, but it reduced its potency in 2K and 2K-1C. The blockade of K channels
reduced the potency of TERPY only in aortic rings of 2K. On the other hand, the potency of SNP was reduced in
both 2K and 2K-1C. The combination of ODQ and TEA reduced the relaxation induced by TERPY and SNP in 2K
and reduced the efﬁcacy to SNP in 2K-1C aortic rings but it had no additional effect on the TERPY relaxation in
2K-1C aortas. The production of cGMP induced by TERPY was greater than that produced by SNP, which was
similarly increased in 2K and 2K-1C. Sarcoplasmic reticulum Ca-ATPase inhibition only impaired the relaxation
induced by SNP in 2K aortic rings.
Signiﬁcance: Taken together, our results provide evidences that in this model of hypertension, impaired K+
channels activation by TERPY and SERCA activation by SNP may contribute to decreased vasodilatation.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Nitric oxide (NO) is a biological signalingmolecule involved not only
in the control of vascular smooth muscle, but also in other regulatory
functions (Moncada et al., 1991). NO is widely distributed and
modulates the physiological functions of the cardiovascular system,
which include vascular smooth muscle relaxation. It has been reported
an endotheliumdysfunction associatedwith hypertension (Puddu et al.,
2000; Lobysheva et al., 2011;Dubin et al., 2011;Michell et al., 2011) and
other cardiovascular diseases (Taddei et al., 1998; Munk et al., 2011;
Yunoki et al., 2011). Some studies regarding renovascular hypertension
in the two kidney, one clip (2K-1C) model have shown that
endothelium-dependent relaxation was decreased as compared with
that in normotensive rats (Angus et al., 1992; Vega et al., 1995; Callera
et al., 2000; Stankevicius et al., 2002; Sendao Oliveira and Bendhack,
2004; Oliveira et al., 2009). The impaired endothelial function could be
associated with decreased production or bioavailability of NO.ologia, Instituto de Ciências
tonio Carlos, 6627, 31270-100
716; fax: +55 31 3409 2695.
ra).
sevier OA license.Since endothelium dysfunction involves decreased production or
bioavailability of endogenous NO and this endothelium dysfunction is
associated with hypertension, the compounds that act as NO donor
could have an important therapeutic effect on the treatment of this
physiopathology. NO donors are potent systemic and collateral
vasodilators. Nitrosyl ruthenium complexes have been studied as a
new class of NOdonors (Bonaventura et al., 2004, 2005, 2006).We have
described a new compound, [Ru(terpy)(bdq)NO]3+ which in vitro
releases NO after tissue metabolization (Bonaventura et al., 2007).
Previous work has demonstrated that this compound induces vasor-
elaxation and cytosolic calcium decrease in the vascular smoothmuscle
cells from normotensive 2K and renal hypertensive 2K-1C rats, which
effects are higher in vessels from normotensive than hypertensive rats
(Bonaventura et al., 2005; Rodrigues et al., 2008). Various cellular
mechanisms have been proposed to explain the decrease of cytosolic
calcium in the vascular smooth muscle cells induced by NO, among
others, direct or cGMP-dependent activation of K+ channels (Bolotina
et al., 1994; Peng et al., 1996) and membrane hyperpolarization,
sarcoplasmic reticulum Ca-ATPase (SERCA) and calcium storage in this
organelle (vanBreemen et al., 1997). It has been reported that not all NO
donors induce vasodilatation by the same mechanisms of cytosolic
calcium decrease, that can be dependent of the mechanism involved in
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Homer et al., 1999).
To date, pharmacologically active compounds that can release NO
such as organic nitrates and sodiumnitroprusside (SNP) havebeenused
as therapeutic agents, but their efﬁcacy is limited by their rapid NO
release (Feelisch, 1993), poor distribution to the target site (Feelisch,
1993), toxicity (Wink et al., 1991) and induction of tolerance (Bauer
et al., 1997). Therefore, newNOdonorswith better pharmacological and
pharmacokinetic properties would be highly desirable.
We tested the hypotheses that cGMP and/or K+ channels activation
are involved in the vasodilatation induced by the NO donors TERPY and
SNP in isolated vessels in which the endothelial cells do not participate,
and that the cellularmechanisms that induce cytosolic calciumdecrease
are different for the NO donors. We also hypothesized that in the
isolated aorta fromrenal hypertensive rats the activation of K+ channels
by NO released from the NO donors is impaired. Therefore, the present
study aimed to investigate the vascular effects of the NO donor TERPY
and SNP in aortas fromnormotensive and renal hypertensive 2 kidney-1
clip (2K-1C) rats.
Materials and methods
Animals
Male Wistar rats (180–200 g) were used in the present study. All
the procedures followed standards and policies of the University of
São Paulo's Animal Care and Use Committee.
Renovascular hypertension was induced in rats following the 2K-1C
Goldblatt model (Goldblatt et al., 1934). Brieﬂy, male Wistar rats
(180–200 g) were anesthetized with tribromoethanol (2.5 mg/kg, i.p.)
and after a midline laparotomy a silver clip with an internal diameter
of 0.20 mm was placed around the left renal artery. Normotensive
two-kidney rats (2K)were only submitted to laparotomy. The ratswere
maintained in a room with controlled temperature, a 12 h light/dark
cycle, and given free access to both standard rat chow and water.
Systolic arterial pressure was measured by an indirect tail-cuff method
6 weeks after surgeries. Rats were considered to be hypertensive when
systolic arterial pressure was higher than 160 mmHg and were used
with 6 weeks after surgery.
Functional studies
Rats were killed by decapitation six weeks after surgery, and the
thoracic aortas were isolated. The aortic rings 4 mm length, were
mounted between two steel hooks connected to an isometric force
transducer (Letica Scientiﬁc Instruments; Barcelona—Spain) tomeasure
tension. The rings were placed in organ chambers containing physio-
logical salt solution (PSS) of the following composition (in mmol/l):
NaCl 130; KCl 4.7; KH2PO4 1.2; MgSO4 1.2; NaHCO3 14.9; glucose 5.5;
CaCl2 1.6. The solutionwasmaintained at pH7.4 and gassedwith 95%O2
and 5% CO2 at 37 °C. After a 60 min equilibration period under a resting
tension of 1.5 g, aortic rings were continuously stimulated with
100 nmol/l phenylephrine (EC50) until reproducible contractile
responses were obtained. All experiments were performed on endo-
thelium-denuded aortic rings. The endotheliumwas removed by gently
rubbing the lumen of the aortic rings. The absence of endothelium was
conﬁrmed by the lack of relaxation response to 1 μmol/l acetylcholine in
aortic rings pre-contracted with 100 nmol/l phenylephrine. After the
equilibration period, speciﬁc protocols were performed in aortic rings
from 2K and 2K-1C rats.
Experimental protocols
Concentration–effect curves for [Ru(terpy)(bdq)NO]3+ and SNP
Aortic rings were pre-contracted with 100 nmol/l phenylephrine.
When the contraction had reached a plateau, cumulative concentra-tion–effect curves to [Ru(terpy)(bdq)NO]3+ (1 nmol/l–300 μmol/l)
were constructed in the 2K and 2K-1C aortic rings. For SNP, when the
contractionhad reachedaplateau cumulative concentration–effect curves
to this NO donor were constructed in aortic rings from normotensive
(0.1 nmol/L–0.3 μmol/l) and hypertensive rats (0.1 nmol/l–30 μmol/l).
Effect of guanylyl cyclase inhibitor on the relaxation induced by the NO
donors [Ru(terpy)(bdq)NO]3+ and SNP
In order to examine the contribution of guanylyl cyclase activation
to the relaxation induced by [Ru(terpy)(bdq)NO]3+ and SNP, the
selective guanylyl cyclase inhibitor (ODQ 1 μmol/l) was incubated for
30 min before the addition of phenylephrine (100 nmol/l). Subse-
quently, after incubationwith ODQ cumulative concentration–response
curves for [Ru(terpy)(bdq)NO]3+ (1 nmol/l to 300 μmol/l) and SNP
(0.1 nmol/l–100 μmol/l) were constructed.
Measurement of cyclic GMP (cGMP) content
For cGMP levelsmeasurement, denuded rat aortas from2K and 2K-1C
rats were incubated with the inhibitor of phosphodiesterase 5 (sildenaﬁl
1 μmol/l) for 30 min. After that, the vessels were exposed to phenyleph-
rine (100 nmol/l) for 10 minor to phenylephrine (100 nmol/l) for 10 min
followed by a 20 min exposure to the concentration that produced 50% of
maximum relaxant effect of [Ru(terpy)(bdq)NO]3+ in aorta from 2K
(300 nmol/l) and 2K-1C (1 μmol/l) rats. For SNP, the preparations were
exposed to phenylephrine (100 nmol/l) for 10 min followed by a 5 min
exposure to the concentration that produced 50% of maximum relaxant
effect of SNP in aorta from 2K (10 nmol/l) and 2K-1C (300 nmol/l) rats.
The vessel segmentswere rapidly frozen in liquid nitrogen, homogenized
in 6% trichloroacetic acid and centrifuged. The supernatant was extracted
with water-saturated diethyl ether for six times. The samples were then
evaporated under nitrogen, and cGMP content was assayed in duplicate
by using a commercially available kit of enzyme immunoassay
(Amersham Biosciences UK Limited, Buckinghamshire—UK). Basal
levels of cGMP were determined as the cGMP content obtained in the
non-stimulated tissues. Results were expressed as fentomoles of cGMP
per milligram of protein. Protein concentrations were determined by
using Folin–Ciocalteau method.
Effect of potassiumchannel blocker and the combination of guanylyl cyclase
inhibitor and potassium channels blocker on the relaxation induced by the
NO donors [Ru(terpy)(bdq)NO]3+ and SNP
In order to examine the contribution of potassium channel
activation to the relaxation induced by [Ru(terpy)(bdq)NO]3+ and
SNP, a non-selective potassium channel blocker tetraethylammonium
(TEA 1 mmol/l) was incubated for 30 min before the addition of
phenylephrine (100 nmol/l). Subsequently, cumulative concentra-
tion–response curves for [Ru(terpy)(bdq)NO]3+ (1 nmol/l to
300 μmol/l) and SNP (0.1 nmol/l–10 μmol/l) were constructed.
To verifywhether the potassium channels are directly activated byNO
released from the NO donor or if the cGMP-dependent pathway is
activated,wehave incubated theaortic ringswith the combinationofODQ
(1 μmol/l) and TEA (1mmol/l) for 30 min before the addition of
phenylephrine (100 nmol/l). After that, cumulative concentration–
response curves for [Ru(terpy)(bdq)NO]3+ (1 nmol/l to 300 μmol/l) and
SNP, in aortic rings from normotensive (0.1 nmol/l–0.3 μmol/l) and
hypertensive rats (0.1 nmol/l–30 μmol/l), were obtained.
Effect of cyclopiazonic acid (CPA) on the relaxation induced by
[Ru(terpy)(bdq)NO]3+
In order to verify whether the sarcoplasmic reticulum Ca2+ ATPase
(SERCA) activation contributes to the relaxation induced by [Ru(terpy)
(bdq)NO]3+ in aortic rings from 2K-1C rats, we studied the effect of the
selective SERCA inhibitor (CPA 10 μmol/l) on this response. CPA was
incubated for 30 min before the addition of phenylephrine
(100 nmol/l). Subsequently, cumulative concentration–response curves
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(0.1 nmol/l–1 μmol/l), were obtained.
Drugs
Acetylcholine, phenylephrine, TEA,ODQ,SNPandCPAwereobtained
from Sigma Chemical (St Louis, MO, USA). [Ru(terpy)(bdq)NO]3+ was
synthesized in the laboratory of Dr. Roberto Santana da Silva (Faculty of
Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo,
Ribeirão Preto, São Paulo, Brazil).
Statistics
Relaxant effects of [Ru(terpy)(bdq)NO]3+ were measured from the
plateau of the phenylephrine contraction and were expressed as
“percent reversal” of the phenylephrine contraction. The maximum
effect (Emax) was considered as the maximal amplitude response
reached in the concentration–effect curves for the relaxant agent. The
concentration of agents that produced a half-maximal relaxation
amplitude (EC50) was determined after logit transformation of the
normalized concentration–response curves and it is reported as
negative logarithm (pD2) of the mean of individual values for each
tissue using the GraphPad Prism version 3.0 (GraphPad Software
Corporation San Diego, CA—USA). Data are expressed as mean±S.E.M.
In each set of experiments, n indicates the number of tissues studied.
Differences betweenmeanvalueshavebeenassessed either byone-way
analysis of variance (ANOVA) followed by a Newman Keuls post-hoc
test and values of Pb0.05 were considered to be signiﬁcant.
Results
Systolic bloodpressurewas signiﬁcantly higher in 2K-1C rats (200±
3.4 mmHg, n=20) as compared with 2K rats (102±4.1 mmHg,
n=24, Pb0.001) 6 weeks after surgery.
Functional studies
Relaxation induced by [Ru(terpy)(bdq)NO]3+and SNPon2Kand2K-1C rat
aortas
Fig. 1 shows the concentration-dependent relaxation response to
[Ru(terpy)(bdq)NO]3+ (A) and SNP (B) in aortic rings from 2K and
2K-1C rats. The pD2 value, but not the maximum effect, was lower in
aortic rings from 2K-1C rats than in aortic rings from 2K rats for both
NO donors studied (Terpy 2K-1C→pD2: 5.85±0.03, Pb0.001, Emax:
101.0±0.6% n=5, and 2K→pD2: 6.77±0.04, Emax: 104.7±1.3%
n=6 and SNP: 2K-1C→pD2: 7.76±0.17, Pb0.05, Emax: 95.4±2.5%,
n=7, and 2K→pD2: 8.22±0.14, Emax: 102.2±3.8% n=6).
Effects of guanylyl cyclase inhibitor on the relaxation induced by
[Ru(terpy)(bdq)NO]3+ and SNP in 2K and 2K-1C rat aortas
The guanylyl cyclase inhibitor ODQ (1 μmol/l), caused a marked
attenuation of the relaxation–response curve to [Ru(terpy)(bdq)NO]3+
in 2K rat aortic rings. As shown in Fig. 2A, ODQ shifted to the right the
concentration–response curve to [Ru(terpy)(bdq)NO]3+ (pD2: 4.81±
0.10, n=10, Pb0.001) but it did not signiﬁcantly change themaximum
effect (92.9±4.6%). On the other hand, the incubation with ODQ
(1 μmol/l) almost abolished the relaxation induced by this NO donor in
2K-1C rat aortic rings (Emax after ODQ: 10.3±3.7%, n=6, Pb0.001)
(Fig. 2B).
Fig. 2C and D show that the relaxation response induced by SNPwas
less potent in thepresence of ODQ in aortic rings from2K and 2K-1C rats
(after ODQ: 2K→pD2: 6.23±0.20, n=4, Pb0.001, 2K-1C→pD2:
5.56±0.27, n=8, Pb0.001). ODQ did not change the maximum effect
of SNP in 2K and 2K-1C aortic rings. However, the reduction in the
potency of SNP induced by ODQwas greater in aortic ring from2K-1C as
compared to 2K.Measurement of cyclic GMP (cGMP) content in 2K and 2K-1C rat aortas
In order to verify the contribution of cGMP to the relaxation induced
by [Ru(terpy)(bdq)NO]3+, we have measured the cGMP concentration
without stimulation (basal), after addition of the contractile agent used
in the functional studies (phenylephrine) and after incubation with
phenylephrine plus [Ru(terpy)(bdq)NO]3+. Phenylephrine did not
increase the cGMP levels as compared to basal cGMP levels in 2K
(basal: 10.71±0.53 fmol/mg of protein, n=5; after phenylephrine:
12.60±1.68 fmol/mg of protein, n=5) and 2K-1C rat aorta (basal:
11.32±0.86 fmol/mg of protein, n=4; after phenylephrine: 10.23±
0.65 fmol/mg of protein, n=5). On the other hand, tissue cGMP
content was similarly increased by SNP (2K: 30.90±1.74 fmol/mg of
protein, n=5 and 2K-1C: 23.09±1.50 fmol/mg of protein, n=4) and
[Ru(terpy)(bdq)NO]3+ (2K: 71.17±5.24 fmol/mg of protein, n=5 and
2K-1C: 75.35±3.35 fmol/mgof protein, n=4) in2Kand2K-1Crat aorta
as compared to the basal levels of cGMP (2K basal: 10.71±
0.53 fmol/mg of protein, n=5; 2K-1C basal: 11.32±0.86 fmol/mg of
protein, n=4) and after stimulation with phenylephrine (2K after
phenylephrine: 12.60±1.68 fmol/mg of protein, n=5; 2K-1C after
phenylephrine: 10.23±0.65 fmol/mg of protein, n=5). Interestingly,
production of cGMP induced by [Ru(terpy)(bdq)NO]3+ was greater
than the production of cGMP induced by SNP in both 2K and 2K-1C
aortic rings (Fig. 3).Effect of potassiumchannel blocker and the combination of guanylyl cyclase
inhibitor and potassium channels blocker on the relaxation induced by the
NO donors [Ru(terpy)(bdq)NO]3+ and SNP in 2K and 2K-1C rat aorta
K+ channels blocker TEA (1 mmol/l) did not alter the Emax for
[Ru(terpy)(bdq)NO]3+ in aortic rings from2K (101.9±1.5%, n=5) and
2K-1C rats (101.8±2.0%, n=7). However, in aortic rings from 2K the
pD2 values were signiﬁcantly reduced from 6.77±0.04 to 5.33±0.09
(n=5, Pb0.001), whereas in 2K-1C aortic rings the pD2 valueswere not
signiﬁcantly altered (before TEA: 5.85±0.03, n=5; after TEA: 5.50±
0.20, n=7) (Fig. 4A and B).
On the other hand, K+ channels blocker did not alter the Emax for
SNP in aortic rings from 2K (106.4±6.0%, n=3) and 2K-1C rats
(98.8±1.5%, n=6) (Fig. 3C and D), similarly that was observed for
[Ru(terpy)(bdq)NO]3+. However, TEA reduced the potency of this NO
donor in aortic rings from 2K (from 8.22±0.14, n=6 to 7.32±0.11,
n=3, Pb0.01) and 2K-1C (before TEA: 7.76±0.17, n=7; after TEA:
7.19±0.18, n=6, Pb0.05) (Fig. 4C and D), but the effect of TEA was
more signiﬁcant in aortic rings from 2K (Pb0.01) than in aortic ring
from 2K-1C (Pb0.05).
As shown in Fig. 5, in the presence of the combination of
ODQ (1 μmol/l) and TEA (1 mmol/l), the relaxation induced by
[Ru(terpy)(bdq)NO]3+ (Fig. 5A and B) and induced by SNP (Fig. 5C
and D) was almost abolished in 2K and 2K-1C rat aorta.Effect of sarcoplasmic reticulum Ca2+-ATPase inhibitor (CPA) on the
relaxation induced by [Ru(terpy)(bdq)NO]3+ in 2K and 2K-1C rat aorta
Incubation with CPA did not alter the relaxation induced by
[Ru(terpy)(bdq)NO]3+ in 2K (Emax: 104.3±2.1% and pD2: 6.62±
0,05, n=6) and 2K-1C rat aorta (Emax: 107.5±1.5% and pD2: 5.85±
0,07, n=8) (Fig. 6A and B).
Different from the data obtained with [Ru(terpy)(bdq)NO]3+, the
relaxation induced by SNP was less potent in normotensive rat aorta in
the presence of CPA than in the absence of this inhibitor (pD2 before
CPA: pD2: 8.22±0.14, n=6 and after CPA: 7.58±0.09, n=3, Pb0.05)
(Fig. 6C), but no differences were observed in Emax values after
incubation with CPA (before CPA: 102.2±3.8% n=6 and after CPA:
99.2±1.4%, n=3). However, the relaxation induced by SNP in aortic
rings from 2K-1C rat was not altered by CPA (before CPA→pD2: 7.76±
0.17, Emax: 95.4±2.5%, n=7, and after CPA→pD2: 7.4±0.16, Emax:
95.8±4.2%, n=8) (Fig. 6D).
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Increased vascular tone, a characteristic feature of most forms of
experimental and human hypertension, has been associated with
impaired NO signaling (Puddu et al., 2000; Schiffrin, 2001; Bae et al.,
2011; Hirooka et al., 2011). Our results showed that vascular reactivity
for [Ru(terpy)(bdq)NO]3+ and SNP in normotensive aortic rings
involves the cGMP pathway and K+ channel activation. On the other
hand, in hypertensive rat aortas the relaxation induced by these nitric
oxidedonorswas lesspotentwhen compared tonormotensive rat aorta.
The impairment in vascular relaxation for SNP in vessels from
hypertensive rats were reported in other studies, such as in SHR rats
(Romero et al., 2009; Ajay et al., 2007).
The mechanisms involved in the vascular relaxation induced by
[Ru(terpy)(bdq)NO]3+ (TERPY) and sodium nitroprusside (SNP) in the
normotensive rat aorta were not discussed because we have previously
published a paper in whichwe have compared the cellularmechanisms
of vasorelaxation inducedbybothNOdonors (Bonaventura et al., 2007).
In thepresent studywe observed various differences in themechanisms
of the vascular relaxation induced by TERPY and SNP. By using speciﬁc
NO species scavengers, hydroxocobalamin and L-cysteine, we have
identiﬁed the contribution of free radical NO (NO•) and nytroxil anion
(NO−), respectively. Our results show that the NO• is the unique NO
specie involved in the SNP-induced relaxation. On the other hand, the
relaxant effect of TERPY involves both NO• and NO−. The production of
cGMP induced by TERPY was higher than that induced by SNP. The
sarcoplasmic reticulum Ca2+-ATPase (SERCA) is not involved in the
relaxation induced by TERPY, but it is important to the relaxation
inducedbySNP. Furthermore, asmentionedby the referee, Rauhala et al.
(1998) veriﬁed that sodium nitroprusside has pro-oxidative properties,
inducing hydroxyl radical generation, lipid peroxidation and cytotox-Fig. 1. Effects of [Ru(terpy)(bdq)NO]3+ and SNP in denuded aortic rings from 2K and
2K-1C rats. Arteries were pre-contracted with phenylephrine and the NO donors
[Ru(terpy)(bdq)NO]3+ and SNP were added cumulatively. Data are the mean±S.E.M.
of n experiments performed on preparations obtained from different animals. *Pb0.05
signiﬁcant difference as compared to Terpy or SNP-relaxation in 2K-1C vs 2K.icity (Rauhala et al., 1998). Pro-oxidative characteristics were not
observed for TERPY. Because of this, it is possible to understandwhy the
vascular mechanisms involved in the vasodilatation induced by TERPY
and SNP are different.
To characterize the mechanism of action evoked by this NO donors
in normotensive and hypertensive rat aorta, various pharmacological
tools were used. ODQ was used as a selective guanylyl cyclase
inhibitor. The inhibitory effect of ODQ is due to changes in the
oxidation state of the haem moiety without adverse effects on the
catalytic activity of the enzyme (Zhao et al., 2000). Although ODQ has
been reported to interfere with haem-protein-dependent process
(Feelisch et al., 1999), it remains the most selective and potent
inhibitor available for soluble guanylyl cyclase. It does not inactivate
NO or the activity of NO-synthase and adenylyl cyclase (Hobbs, 1997).
The inhibition of smooth muscle relaxation in rat aorta from
normotensive and hypertensive rats correlates with the blockade of
cGMP accumulation, which indicates an important contribution of
cGMP to the arterial relaxation evoked by [Ru(terpy)(bdq)NO]3+ and
SNP. The relevanceof sGCactivation toNOdonor-induced relaxationwas
reported in other studies (Bonaventura et al., 2005; Soloviev et al., 2004;
Keeble et al., 2001; Sathishkumar et al., 2005; Cogolludo et al., 1999;
Tsenget al., 2000). In thepresent study, the inhibitoryeffect ofODQon the
relaxation induced by [Ru(terpy)(bdq)NO]3+was higher in hypertensive
rat aorta, since the relaxation was almost blocked when compared to
normotensive rats. Based in these resultswe can suggest that the guanylyl
cyclase activation plays a more important role on the relaxation induced
by [Ru(terpy)(bdq)NO]3+ in aortic rings from 2K-1C than in 2K.
The results obtained with the complex [Ru(terpy)(bdq)NO]3+ are in
accordance to previous results reported by our group (Bonaventura et al.,
2005), in which the relaxation induced by another ruthenium complex
that acts as NO donor (trans-[RuCl([15]aneN4)NO]2+), is totally
dependent on sGC activation in 2K-1C rat aorta.
On the other hand, although the SNP-induced relaxationwas shifted
to the right in the presence of ODQ in normotensive and hypertensive
rat aorta, there was no difference between the relaxations induced by
SNP in aortic rings from normotensive or hypertensive rats in the
presence of ODQ. These results suggest that the difference observed in
the relaxation induced by SNP in aortas from 2K and 2K-1C rats in the
absence of ODQ could not be related to a reduction on cGMP production
in hypertensive rat aortas. Our results for SNP in normotensive rat aorta
are in agreement with Callera et al. (2004).
Since sGC activation seems to be the most important pathway
involved in the relaxation induced by [Ru(terpy)(bdq)NO]3+ in 2K-1C
rat aorta and it seems to be the principal factor involved in the reduction
inpotencyof SNP in the2K-1C rat aorta relaxation,we aimed tomeasure
the production of cGMP induced by [Ru(terpy)(bdq)NO]3+ and SNP in
rat aorta from 2K and 2K-1C. Our results show that in normotensive and
hypertensive rat aorta [Ru(terpy)(bdq)NO]3+ and SNP have enhanced
the tissue cGMP production at similar levels. There is no difference
between normotensive and hypertensive rat aortas. These data are in
accordance with Callera et al. (2004). These authors observed that the
enhancement in cGMP content induced by acetylcholine is similar
between 2K and 2K-1C rat aorta. Therefore, our results suggest that 2K-
1C hypertension is not related to the reduction in cGMP synthesis.
Since cGMP content was not different in aortas from 2K and 2K-1C
rats, we investigated if there is some problem in cGMP-dependent
signaling pathway in aortas from 2K-1C rat as compared to 2K rats.
Most of the cellular mechanisms of NO-induced vasodilatation are
mediated through the activation of sGC,which catalyzes the conversionof
guanosine 5-trisphosphate (GTP) to cGMP (Feelisch and Noack, 1987;
Martin et al., 2000; Irvine et al., 2003). The cGMP thus formed acts as a
second messenger activating cGMP-dependent protein kinase (PKG) and
facilitating the phosphorylation of various proteins, such as K+ channels
and sarcoplasmic reticulumCa2+-ATPase (SERCA), that leads to reduction
of cytosolic Ca2+ concentration and consequently vasorelaxation (Walter,
1989; Murad, 1994; Ishibashi et al., 1998; Mistry and Garland, 1998). On
Fig. 2. Concentration–response curves to [Ru(terpy)(bdq)NO]3+ and SNP in denuded aortic rings from 2K (A and C) and 2K-1C (B and D) in the absence or presence of ODQ, a
selective soluble guanylyl cyclase inhibitor. Data are means±S.E.M. of n experiments performed on preparations obtained from different animals. *Pb0.001 signiﬁcant difference as
compared to Terpy or SNP-relaxation in 2K and 2K-1C in the presence or absence of ODQ.
599D. Bonaventura et al. / Life Sciences 89 (2011) 595–602the other hand, NO can induce vasodilatation throughout direct K+
channel activation (Tare et al., 1990). When K+ channels open in the
vascular smooth muscle cell membrane, K+ efﬂux increases, causing
membrane hyperpolarization, decreased Ca2+ entry through voltage-
operated Ca2+ channels and vasodilatation. Based on these facts, we
investigated the participation of K+ channels and SERCA in the vascular
relaxation induced by [Ru(terpy)(bdq)NO]3+ and SNP in aortas from 2K
and 2K-1C rats.
Altered vascular K+ channels function under pathological condi-
tions could be either a cause or an effect of the disease (Sobey, 2001).
Several studies have shown that the function of the different subtypes
of K+ channels is impaired in hypertension (Callera et al., 2004;Fig. 3. Production of tissue cGMP by [Ru(terpy)(bdq)NO]3+ and SNP in denuded rat aorta
from2Kand2K-1C rats. Aortic ringswere treatedornot (basal)with phenylephrine (Phe),
phenylephrine plus [Ru(terpy)(bdq)NO]3+ (Terpy) or phenylephrine plus SNP. Values are
themean±S.E.M. from four to ﬁve independent determinations. *Pb0.05 for tissue cGMP
production by SNP vs basal or phenylephrine production. #Pb0.001 for tissue cGMP
production by [Ru(terpy)(bdq)NO]3+vs basal, phenylephrine or SNP production.Borges et al., 1999; Cox, 2002). The main ﬁnding of the present study
is that the impaired relaxation to [Ru(terpy)(bdq)NO]3+ in aortic
rings from 2K-1C rats could be related to failed K+ channel activation.
Several mechanisms have been proposed to explain the vasodilatation
induced by NO, including membrane hyperpolarization to direct
(Bolotina et al., 1994) or indirect cGMP-dependent (Robertson et al.,
1993; Archer et al., 1994) activation. Previous results of our group
have shown that in this model of hypertension, the reduced NO-
mediated vasodilatation induced by acetylcholine in rat aorta is due to
impaired activation of KCa channels (Callera et al., 2004). In the
present study, it is reasonable to suggest that the decreased
vasodilatation induced by [Ru(terpy)(bdq)NO]3+ in 2K-1C rats is
due to the failed activation of K+ channels. Based on the fact that in
2K-1C rat aorta, K+ channels are not activated and the cGMP content
is similar between normotensive and hypertensive rats, it could
explain the reduced relaxation induced by [Ru(terpy)(bdq)NO]3+ in
hypertensive rats when compared to normotensive rat aorta.
It has been previously reported that Ca2+ uptake into intracellular
stores by sarcoplasmic reticulum Ca2+-ATPase (SERCA) is normally
involved in the aorta relaxation induced by NO. In the current study,
we have shown that the selective SERCA inhibitor CPA, did not alter
[Ru(terpy)(bdq)NO]3+-induced relaxation in denuded rat aorta from
normotensive and hypertensive rats. These results obtained in
normotensive rats are in accordance with Bonaventura et al. (2007)
that have characterized the mechanisms involved in the relaxation
induced by [Ru(terpy)(bdq)NO]3+ in rat aorta. On the other hand,
when we investigated the involvement of SERCA in the SNP-induced
relaxation in 2K and 2K-1C rat aorta, we observed that the Ca2+ pump
is important to SNP relaxation in 2K rat aorta. However, in 2K-1C rat
aortas the relaxation induced by SNP is not altered by the selective
SERCA inhibitor, CPA. Taken together, our results suggest that SERCA
activation does not contribute to the relaxation induced by SNP in 2K-
1C rat aorta.
Fig. 4. Concentration–response curves to [Ru(terpy)(bdq)NO]3+ and SNP indenuded aortic rings from2K(A and C) and 2K-1C (B andD) in the absence or presence of TEA, a non-selective
K+ channels blocker. Data are means±S.E.M. of n experiments performed on preparations obtained from different animals. *Pb0.05 signiﬁcant difference as compared to Terpy or SNP-
relaxation in 2K and 2K-1C in the presence or absence of TEA.
Fig. 5. Concentration–response curves to [Ru(terpy)(bdq)NO]3+ and SNP in denuded aortic rings from 2K (A and C) and 2K-1C (B and D) in the absence or presence of ODQ+TEA.
Data are means±S.E.M. of n experiments performed on preparations obtained from different animals. *Pb0.0001 signiﬁcant difference as compared to Terpy or SNP-relaxation in 2K
and 2K-1C in the presence or absence of ODQ+TEA.
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Fig. 6. Effect of cyclopiazonic acid (CPA) on the relaxation induced by [Ru(terpy)(bdq)NO]3+ and SNP in 2K (A and C) and 2K-1C (B and D) denuded rat aortas. Data are means±
S.E.M. of n experiments performed on preparations obtained from different animals. *Pb0.001 signiﬁcant difference as compared to Terpy or SNP-relaxation in 2K and 2K-1C in the
presence or absence of CPA.
601D. Bonaventura et al. / Life Sciences 89 (2011) 595–602Conclusions
In conclusion, the present study shows that the K+ channel and
sarcoplasmic reticulum Ca2+-ATPase do not play an important role in
the relaxation induced by the NO donors [Ru(terpy)(bdq)NO]3+ and
SNP, respectively, in aorta from 2K-1C hypertensive rat. The results
provide evidence that, in this model of hypertension, impaired K+
channels activation by [Ru(terpy)(bdq)NO]3+ and SERCA activation by
SNP may contribute to decreased vasodilatation in response to
exogenous NO.
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